Thus, the observed regulation of p21 expression, such as factors involved in EMT, stemness, or angiogenesis, appear to be linked to the resistance mechanisms of surviving GBM cells induced upon TMZ+AT101/AT101 treatment. This evidence concerns the gene CDKN1A and glioblastoma.